Literature DB >> 8852369

Transient compartmental expression of a family of protein tyrosine phosphatases in the developing striatum.

A Raghunathan1, G A Matthews, P J Lombroso, J R Naegele.   

Abstract

The expression of a family of intracellular protein tyrosine phosphatases (STEP) was studied in the striatum of rats during ontogeny. Links between the formation of dopamine islands and STEP immunoreactive patches in the striatum were examined since previous work had suggested that STEP isoforms were selectively expressed in dopaminoceptive brain regions. STEP protein and mRNAs were distributed in a patchy manner during the first postnatal week. By 2 weeks, STEP immunoreactivity was homogeneous, indicating that both patch and matrix neurons express STEP by maturity. Two-color immunofluorescent staining was also performed to compare STEP with specific markers for patch and matrix. Tyrosine hydroxylase immunoreactive fibers from the substantia nigra form distinctive dopamine islands in the striatum during late embryonic development, and occupy the sites of future patches [23,37,38,54]. These fiber islands align with STEP immunoreactive neuronal patches during the first two postnatal weeks, suggesting that STEP is a marker for patch neurons in early postnatal development. When STEP's distribution was compared with other markers for patch (substance P) or matrix (calbindin), STEP co-localized with substance P in most striatal neurons on postnatal days 1 through 7. However, STEP was also expressed within a subset of calbindin-positive neurons in the lateral striatum, but not with these neurons elsewhere in the striatum. By adulthood, STEP colocalized with both markers. These results suggest that STEP is expressed first within patch neurons but not matrix, and subsequently within both. The expression of STEP may be triggered by the arrival of striatal afferents or other regulatory factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852369     DOI: 10.1016/0165-3806(95)00176-x

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  11 in total

1.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

Review 2.  Taking STEPs forward to understand fragile X syndrome.

Authors:  Susan M Goebel-Goody; Paul J Lombroso
Journal:  Results Probl Cell Differ       Date:  2012

3.  STEP61: a member of a family of brain-enriched PTPs is localized to the endoplasmic reticulum.

Authors:  A Bult; F Zhao; R Dirkx; E Sharma; E Lukacsi; M Solimena; J R Naegele; P J Lombroso
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

Review 4.  Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease.

Authors:  Jian Xu; Pradeep Kurup; Angus C Nairn; Paul J Lombroso
Journal:  Adv Pharmacol       Date:  2012

Review 5.  Regulation of signaling by protein-tyrosine phosphatases: potential roles in the nervous system.

Authors:  C O Arregui; J Balsamo; J Lilien
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

6.  Altered Intracellular Calcium Homeostasis Underlying Enhanced Glutamatergic Transmission in Striatal-Enriched Tyrosine Phosphatase (STEP) Knockout Mice.

Authors:  Federica Bosco; Pierluigi Valente; Marco Milanese; Alessandra Piccini; Mirko Messa; Giambattista Bonanno; Paul Lombroso; Pietro Baldelli; Fabio Benfenati; Silvia Giovedì
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

Review 7.  Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.

Authors:  Susan M Goebel-Goody; Matthew Baum; Constantinos D Paspalas; Stephanie M Fernandez; Niki C Carty; Pradeep Kurup; Paul J Lombroso
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

8.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

9.  PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61.

Authors:  Sehoon Won; Salvatore Incontro; Roger A Nicoll; Katherine W Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

Review 10.  Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.

Authors:  Takatoshi Karasawa; Paul J Lombroso
Journal:  Neurosci Res       Date:  2014-09-10       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.